Literature DB >> 16380235

The 2-year stability of neurological soft signs after a first episode of non-affective psychosis.

Marco P M Boks1, Jean-Paul Selten, Stuart Leask, Robert J Van den Bosch.   

Abstract

We examined the 2-year stability of neurological soft signs (NSS) in 29 patients after a first episode of psychosis. The numbers of NSS at inclusion and at 2 years follow-up were similar, but there was a significant increase in the numbers of NSS in the sub-group of patients whose dosage of antipsychotic medication had increased over time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380235     DOI: 10.1016/j.eurpsy.2005.09.004

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  5 in total

1.  Neurological soft signs in schizophrenia: a meta-analysis.

Authors:  Raymond C K Chan; Ting Xu; R Walter Heinrichs; Yue Yu; Ya Wang
Journal:  Schizophr Bull       Date:  2009-04-17       Impact factor: 9.306

Review 2.  Neurological soft signs in the clinical course of schizophrenia: results of a meta-analysis.

Authors:  Silke Bachmann; Christina Degen; Franz Josef Geider; Johannes Schröder
Journal:  Front Psychiatry       Date:  2014-12-23       Impact factor: 4.157

3.  Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis.

Authors:  Paolo Fusar-Poli; Marco Cappucciati; Grazia Rutigliano; Margaret Heslin; Daniel Stahl; Zera Brittenden; Edgardo Caverzasi; Philip McGuire; William T Carpenter
Journal:  Schizophr Bull       Date:  2016-03-15       Impact factor: 9.306

Review 4.  Neurological Soft Signs in Schizophrenia: An Update on the State- versus Trait-Perspective.

Authors:  Silke Bachmann; Johannes Schröder
Journal:  Front Psychiatry       Date:  2018-01-08       Impact factor: 4.157

5.  Neurological Signs at the First Psychotic Episode as Correlates of Long-Term Outcome: Results From the AESOP-10 Study.

Authors:  Naika P Ferruccio; Sarah Tosato; Julia M Lappin; Margaret Heslin; Kim Donoghue; Annalisa Giordano; Ben Lomas; Ulrich Reininghaus; Adanna Onyejiaka; Raymond C K Chan; Tim Croudace; Peter B Jones; Robin M Murray; Paul Fearon; Gillian A Doody; Craig Morgan; Paola Dazzan
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.